Related Experiment Videos
[Cutaneous and subcutaneous hematomas observed in dermatology: 17 cases]
E Estève1, P Armingaud, L Martin
1Service de Dermatologie, CHR Orléans, Hôpital Porte Madeleine, BP 2439, 45032 Orléans Cedex 1. eric.esteve@chr-orleans.fr
Annales De Dermatologie Et De Venereologie
|August 20, 2004
Summary
Cutaneous hematomas frequently affect elderly patients on anticoagulant therapy, often presenting as inflammatory leg swellings. Overdosing of anticoagulant medications is common, highlighting the need for dermatologists to recognize these cases.
Area of Science:
- Dermatology
- Hematology
Context:
- Cutaneous hematomas are a common cause of dermatological hospitalizations.
- Diagnosis can be challenging, mimicking conditions like thrombophlebitis or abscesses.
Purpose:
- To determine the frequency, clinical presentation, and circumstances of cutaneous hematoma hospitalizations.
- To analyze patient demographics, treatment, and outcomes.
Summary:
- A retrospective study of 17 hospitalized patients (mean age 71) with leg hematomas revealed that 13 were on anticoagulant or anti-platelet therapy.
- Hematomas were frequently inflammatory or infected, with 7 patients experiencing fever.
- Therapeutic overdosing of anticoagulants (antivitamin K, low molecular weight heparin) was documented in 5 of 9 treated patients.
Impact:
- Highlights the prevalence of anticoagulant-related hematomas in the elderly population.
- Emphasizes the need for dermatologists to be aware of the clinical features and risk factors for cutaneous hematomas.
- Suggests improved monitoring of anticoagulant therapy to prevent overdosing and related complications.